Information For DPL XXXVI
The American Society for Pharmacy Law (ASPL) is an organization of attorneys, pharmacists, pharmacist-attorneys and students of pharmacy or law who are interested in the law as it applies to pharmacy, pharmacists, wholesalers, manufacturers, state and federal government and other interested parties.

ASPL is a non-profit which encourages diversity & inclusion with the Society, regardless of differing backgrounds, perspectives, experiences, orientations, origins, and practice settings. The Society embraces participation and diversity as it leads to advancing our purpose: 

  • Furthering knowledge in the law related to pharmacists, pharmacies, the provision of pharmaceutical care, the manufacturing and distribution of drugs, and other food, drug, and medical device policy issues;
  • Communicating accurate legal educational information; and
  • Providing educational opportunities for pharmacists, attorneys, and others who are interested in pharmacy law

Latest News

August 26, 2025

FDA Begins Daily Adverse Event Data Publication

The U.S. Food and Drug Administration (FDA) has begun daily publication of adverse event data from the FDA Adverse Event Reporting System (FAERS). According to FDA, this represents a significant step forward in modernizing the agency’s safety monitoring infrastructure and demonstrates its commitment to radical transparency and real-time protection of public health.

FAERS is the FDA's primary database for collecting and analyzing adverse event reports, serious medication errors, and product quality complaints for prescription drugs and therapeutic biologics, containing reports submitted by healthcare professionals, consumers, and manufacturers.

The public can view the latest adverse event data on the FAERS Public Dashboard. Healthcare professionals and consumers are encouraged to report adverse events to the FDA’s MedWatch site.

[FDA Begins Real-Time Reporting of Adverse Event Data. FDA 22 Aug 2025.]